PulseCath Overview

  • Founded
  • 2007
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Debt
  • Latest Deal Amount
  • $3.36M
Latest Deal Amount
  • Investors
  • 3

PulseCath General Information


Developer of a circulatory support technology designed to assist the life-sustaining pumping functions of the failing heart. The company's devices help to generate blood-flow and can be inserted through the femoral artery, enabling cardiologists and cardiac surgeons to provide reliable life support to their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Primary Office
  • Nieuwe Stationsstraat 20
  • 14th Floor
  • 6811 KS Arnhem
  • Netherlands
+31 026 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PulseCath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - General 10-Oct-2016 $3.36M 00.000 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view PulseCath’s complete valuation and funding history, request access »

PulseCath Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of a circulatory support technology designed to assist the life-sustaining pumping functions of the failing he
Surgical Devices
Arnhem, Netherlands
8 As of 2021
000000000 00.000


Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000000000 000000000
Danvers, MA
0000 As of 0000
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PulseCath Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 Corporation Danvers, MA 0000 000.00 00000000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

PulseCath Executive Team (5)

Name Title Board Seat Contact Info
Yoram Karmon Ph.D Chief Executive Officer and President
Robert Prince Chief Financial Officer
Oren Malkin Vice President, Marketing & Sales
You’re viewing 3 of 5 executive team members. Get the full list »

PulseCath Board Members (1)

Name Representing Role Since
Willem van Lawick MD MedSciences Capital Chairman & Board Member 000 0000
To view PulseCath’s complete board members history, request access »

PulseCath Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PulseCath Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Health Innovations Venture Capital Minority 000 0000 000000 0
MedSciences Capital Venture Capital Minority 000 0000 000000 0
Oost NL Venture Capital Minority 000 0000 000000 0
To view PulseCath’s complete investors history, request access »